Alabama Nursing Board Defense Lawyer – Call Today – Hydrocodone products to get Schedule II classification – (866) 348-2889

Combination hydrocodone products, currently considered Schedule III drugs, will be reclassified as Schedule II because of their high risk for abuse, according to a new regulation issued by the U.S. Drug Enforcement Administration, which will take effect in in October.

The DEA’s Final Rule, published Aug. 22, said the decision to move hydrocodone combination products to the more-restrictive Schedule II, which are those with as drugs with a high potential for abuse, was based on recommendations by the Department of Health and Human Services and supported by the DEA’s evaluation of relevant data.

Click Here to Read More